Suppr超能文献

一群艾滋病毒呈阳性女性的生殖健康需求与愿望

Reproductive healthcare needs and desires in a cohort of HIV-positive women.

作者信息

Badell Martina L, Lathrop Eva, Haddad Lisa B, Goedken Peggy, Nguyen Minh Ly, Cwiak Carrie A

机构信息

Department of Gynecology and Obstetrics, Emory University, Atlanta, GA 30306, USA.

出版信息

Infect Dis Obstet Gynecol. 2012;2012:107878. doi: 10.1155/2012/107878. Epub 2012 Jun 13.

Abstract

BACKGROUND

The aim of this study was to determine current contraceptive use, contraceptive desires and knowledge, future fertility desires, and sterilization regret in a cohort of HIV-positive women.

STUDY DESIGN

127 HIV-positive women receiving care at an urban infectious disease clinic completed a survey addressing their contraceptive and reproductive histories as well as their future contraceptive and fertility desires.

RESULTS

The most common forms of contraception used were sterilization (44.4%) and condoms (41.3%). Less than 1% used a long-term reversible method of contraception (LARC) despite these being the methods that best fit their desired attributes of a contraceptive method. Overall, 29.4% desired future fertility. Only 50.6% of those sexually active had spoken with a provider within the last year regarding their contraceptive plans. There was a high degree of sterilization regret (36.4%), and 18.2% of sterilized women desired future fertility. Multivariate analysis found women in a monogamous relationship had a statistically increased rate of regret compared to women who were not sexually active (OR 13.8, 95% CI 1.6-119, P = 0.17).

CONCLUSION

Given the diversity in contraceptive and fertility desires, coupled with a higher rate of sterilization regret than is seen in the general population, integration of comprehensive family planning services into HIV care via increased contraceptive education and access is imperative.

摘要

背景

本研究的目的是确定一组艾滋病毒阳性女性目前的避孕措施使用情况、避孕意愿和知识、未来生育意愿以及绝育后悔情况。

研究设计

127名在城市传染病诊所接受治疗的艾滋病毒阳性女性完成了一项调查,该调查涉及她们的避孕和生育史以及未来的避孕和生育意愿。

结果

最常用的避孕方式是绝育(44.4%)和避孕套(41.3%)。尽管长效可逆避孕方法(LARC)是最符合她们对避孕方法期望属性的方法,但使用该方法的女性不到1%。总体而言,29.4%的女性希望未来生育。在过去一年中,只有50.6%的性活跃女性与医疗服务提供者讨论过她们的避孕计划。绝育后悔程度较高(36.4%),18.2%的绝育女性希望未来生育。多变量分析发现,与无性活跃的女性相比,处于一夫一妻制关系中的女性后悔率在统计学上有所增加(比值比13.8,95%置信区间1.6 - 119,P = 0.17)。

结论

鉴于避孕和生育意愿的多样性,再加上绝育后悔率高于普通人群,通过加强避孕教育和增加避孕服务可及性,将综合计划生育服务纳入艾滋病毒护理势在必行。

相似文献

1
Reproductive healthcare needs and desires in a cohort of HIV-positive women.
Infect Dis Obstet Gynecol. 2012;2012:107878. doi: 10.1155/2012/107878. Epub 2012 Jun 13.
2
Contraception and fertility plans in a cohort of HIV-positive women in care.
Contraception. 2007 Apr;75(4):294-8. doi: 10.1016/j.contraception.2006.12.012. Epub 2007 Feb 22.
3
The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda.
Contraception. 2015 Aug;92(2):152-9. doi: 10.1016/j.contraception.2015.04.011. Epub 2015 May 14.
4
Condom use with main partners by sterilized and non-sterilized women.
Women Health. 1997;25(2):65-85. doi: 10.1300/J013v25n02_04.
5
Trends in contraception and sterilization in Australia.
Aust N Z J Obstet Gynaecol. 1991 Aug;31(3):201-8. doi: 10.1111/j.1479-828x.1991.tb02781.x.
6
Factors associated with sterilization among HIV-positive US women in an urban outpatient clinic.
AIDS Care. 2017 May;29(5):612-617. doi: 10.1080/09540121.2016.1255710. Epub 2016 Dec 4.
7
Contraception choices in a cohort of HIV+ women in the era of highly active antiretroviral therapy.
Contraception. 2011 Jul;84(1):94-7. doi: 10.1016/j.contraception.2010.10.012. Epub 2010 Dec 3.
10
Contraceptive method and self-reported HIV status among women in Malawi.
Contraception. 2017 Jun;95(6):558-563. doi: 10.1016/j.contraception.2017.03.001. Epub 2017 Mar 8.

引用本文的文献

1
HIV Infections and Prevention in Women.
Clin Obstet Gynecol. 2025 Jun 1;68(2):159-163. doi: 10.1097/GRF.0000000000000939. Epub 2025 Mar 25.
2
Pregnancy incidence, outcomes and associated factors in a cohort of women living with HIV/AIDS in Rio de Janeiro, Brazil, 1996-2016.
Cad Saude Publica. 2023 Jul 17;39(6):e00232522. doi: 10.1590/0102-311XEN232522. eCollection 2023.
4
Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011.
Contraception. 2021 Apr;103(4):225-231. doi: 10.1016/j.contraception.2020.11.004. Epub 2020 Nov 12.
5
A comparative analysis of documented contraceptive use among women aged 18-30 living with and without HIV in Alabama.
Contraception. 2019 Oct;100(4):275-278. doi: 10.1016/j.contraception.2019.06.012. Epub 2019 Jun 23.
6
Improved Perinatal and Postpartum Human Immunodeficiency Virus Outcomes After Use of a Perinatal Care Coordination Team.
Open Forum Infect Dis. 2019 Apr 9;6(6):ofz183. doi: 10.1093/ofid/ofz183. eCollection 2019 Jun.
7
Parenting Desires Among Individuals Living With Human Immunodeficiency Virus in the United States.
Open Forum Infect Dis. 2018 Sep 15;5(10):ofy232. doi: 10.1093/ofid/ofy232. eCollection 2018 Oct.
8
Reproductive desire among women living with HIV/AIDS in Central Brazil: Prevalence and associated factors.
PLoS One. 2017 Oct 20;12(10):e0186267. doi: 10.1371/journal.pone.0186267. eCollection 2017.
10
"When Should I Tell?": Perspectives on Disclosure to Their Children among Parents with Perinatally Acquired HIV.
Front Public Health. 2016 Jun 30;4:140. doi: 10.3389/fpubh.2016.00140. eCollection 2016.

本文引用的文献

1
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.
Lancet Infect Dis. 2012 Jan;12(1):19-26. doi: 10.1016/S1473-3099(11)70247-X. Epub 2011 Oct 3.
2
ACOG Practice Bulletin No. 117: Gynecologic care for women with human immunodeficiency virus.
Obstet Gynecol. 2010 Dec;116(6):1492-1509. doi: 10.1097/AOG.0b013e3182054cae.
3
Use of contraception in the United States: 1982-2008.
Vital Health Stat 23. 2010 Aug(29):1-44.
4
Global development. Family planning and the Millennium Development Goals.
Science. 2010 Sep 24;329(5999):1603. doi: 10.1126/science.1197080. Epub 2010 Sep 16.
5
Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative.
AIDS. 2009 Nov;23 Suppl 1(0 1):S69-77. doi: 10.1097/01.aids.0000363779.65827.e0.
6
Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review.
AIDS. 2009 Nov;23 Suppl 1:S55-67. doi: 10.1097/01.aids.0000363778.58203.b6.
7
Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.
Contraception. 2008 Feb;77(2):84-90. doi: 10.1016/j.contraception.2007.10.002. Epub 2007 Dec 21.
8
Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy.
Fertil Steril. 2008 Oct;90(4):965-71. doi: 10.1016/j.fertnstert.2007.07.1348. Epub 2007 Sep 19.
9
Preconception health care for HIV-infected women.
Top HIV Med. 2007 Aug-Sep;15(4):137-41.
10
Contraceptive use among U.S. women with HIV.
J Womens Health (Larchmt). 2007 Jun;16(5):657-66. doi: 10.1089/jwh.2006.0204.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验